MXPA02010545A - Cristal estable novedoso de derivado de tiazolidinediona y proceso para producir el mismo. - Google Patents
Cristal estable novedoso de derivado de tiazolidinediona y proceso para producir el mismo.Info
- Publication number
- MXPA02010545A MXPA02010545A MXPA02010545A MXPA02010545A MXPA02010545A MX PA02010545 A MXPA02010545 A MX PA02010545A MX PA02010545 A MXPA02010545 A MX PA02010545A MX PA02010545 A MXPA02010545 A MX PA02010545A MX PA02010545 A MXPA02010545 A MX PA02010545A
- Authority
- MX
- Mexico
- Prior art keywords
- producing
- same
- stable crystal
- novel stable
- thiazolidinedione derivative
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/34—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C30—CRYSTAL GROWTH
- C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
- C30B7/00—Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- Metallurgy (AREA)
- Materials Engineering (AREA)
- Crystallography & Structural Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Un cristal homogeneo que tiene una excelente estabilidad adecuado para la produccion en escala industrial de 5-[(2, 4-dioxotiazolidin -5-il)metil] -2-metoxi-N -[[4-(trifluorometil) fenil] benzamida (KRP-297). El cristal novedoso de KRP-297 se produce a traves de una recristalizacion procedente de un solvente de alcohol. Esta caracterizado por tener angulos de difraccion (28) en al menos 9.7°, 15.0°, 22.5° en difractometria de polvo de rayos X.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000124006 | 2000-04-25 | ||
| PCT/JP2001/003450 WO2001081327A1 (fr) | 2000-04-25 | 2001-04-23 | Nouveau cristal stable de derive thiazolidinedione et son procede de production |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA02010545A true MXPA02010545A (es) | 2004-05-14 |
Family
ID=18634205
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA02010545A MXPA02010545A (es) | 2000-04-25 | 2001-04-23 | Cristal estable novedoso de derivado de tiazolidinediona y proceso para producir el mismo. |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US6770133B2 (es) |
| EP (1) | EP1277745A4 (es) |
| KR (1) | KR20030007548A (es) |
| CN (1) | CN1426402A (es) |
| AU (1) | AU4882801A (es) |
| BG (1) | BG107200A (es) |
| BR (1) | BR0110258A (es) |
| CA (1) | CA2407349A1 (es) |
| CZ (1) | CZ20023502A3 (es) |
| EA (1) | EA004244B1 (es) |
| EE (1) | EE200200601A (es) |
| HK (1) | HK1053835A1 (es) |
| HU (1) | HUP0300475A3 (es) |
| IL (1) | IL152224A0 (es) |
| IS (1) | IS6586A (es) |
| MA (1) | MA25664A1 (es) |
| MX (1) | MXPA02010545A (es) |
| NO (1) | NO20025069D0 (es) |
| PL (1) | PL365533A1 (es) |
| SK (1) | SK15142002A3 (es) |
| WO (1) | WO2001081327A1 (es) |
| YU (1) | YU80302A (es) |
| ZA (1) | ZA200208293B (es) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE340168T1 (de) * | 2000-02-01 | 2006-10-15 | Kyorin Seiyaku Kk | Alkalimetallsalz von thiazolidin-2,4-dion- derivaten |
| JPWO2003062214A1 (ja) * | 2002-01-23 | 2005-05-19 | 杏林製薬株式会社 | ベンジルチアゾリジンジオン誘導体の新規な安定結晶とその製法 |
| DE10308353A1 (de) | 2003-02-27 | 2004-12-02 | Aventis Pharma Deutschland Gmbh | Diarylcycloalkylderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| US7148246B2 (en) | 2003-02-27 | 2006-12-12 | Sanofi-Aventis Deutschland Gmbh | Cycloalkyl derivatives having bioisosteric carboxylic acid groups, processes for their preparation and their use as pharmaceuticals |
| DE10308352A1 (de) | 2003-02-27 | 2004-09-09 | Aventis Pharma Deutschland Gmbh | Arylcycloalkylderivate mit verzweigten Seitenketten, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel |
| DE10308355A1 (de) | 2003-02-27 | 2004-12-23 | Aventis Pharma Deutschland Gmbh | Aryl-cycloalkyl substituierte Alkansäurederivate, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel |
| DE10308351A1 (de) | 2003-02-27 | 2004-11-25 | Aventis Pharma Deutschland Gmbh | 1,3-substituierte Cycloalkylderivate mit sauren, meist heterocyclischen Gruppen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| KR20060109926A (ko) | 2003-11-19 | 2006-10-23 | 메타베이시스 테라퓨틱스, 인크. | 새로운 인-함유 갑상선 호르몬 모방약들 |
| DE602004004631D1 (de) | 2004-04-01 | 2007-03-22 | Sanofi Aventis Deutschland | Oxadiazolone, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Pharmazeutika |
| DE102005026762A1 (de) | 2005-06-09 | 2006-12-21 | Sanofi-Aventis Deutschland Gmbh | Azolopyridin-2-on-derivate als Inhibitoren von Lipasen und Phospholipasen |
| TWI383008B (zh) * | 2005-08-17 | 2013-01-21 | Nippon Catalytic Chem Ind | 吸水性樹脂之製造方法及吸水性樹脂以及其利用 |
| TW201336497A (zh) | 2007-02-08 | 2013-09-16 | Daiichi Sankyo Co Ltd | 噻唑啶二酮化合物之結晶型及其製法 |
| WO2010093601A1 (en) | 2009-02-10 | 2010-08-19 | Metabasis Therapeutics, Inc. | Novel sulfonic acid-containing thyromimetics, and methods for their use |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4864028A (en) * | 1983-09-14 | 1989-09-05 | Alcon Laboratories, Inc. | Spiro-tricyclicaromatic succinimide derivatives |
| CN1003445B (zh) * | 1984-10-03 | 1989-03-01 | 武田药品工业株式会社 | 噻唑烷二酮衍生物，其制备方法和用途 |
| AR240698A1 (es) * | 1985-01-19 | 1990-09-28 | Takeda Chemical Industries Ltd | Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales |
| JP3053490B2 (ja) | 1991-02-25 | 2000-06-19 | 杏林製薬株式会社 | チアゾリジン−２，４−ジオン誘導体とその塩及び製造法 |
| JPH04270273A (ja) | 1991-02-25 | 1992-09-25 | Kyorin Pharmaceut Co Ltd | チアゾリジン−２，４−ジオン誘導体とその塩及びその製造法 |
| JP3644998B2 (ja) | 1995-02-09 | 2005-05-11 | 塩野義製薬株式会社 | ベンジリデン誘導体の結晶の選択的取得方法 |
| US6147101A (en) * | 1995-06-02 | 2000-11-14 | Kyorin Pharmaceutical Co., Ltd. | N-benzyldioxothiazolidylbenzamide derivatives and process for producing the same |
| JP3144624B2 (ja) * | 1995-06-02 | 2001-03-12 | 杏林製薬株式会社 | Ｎ−ベンジルジオキソチアゾリジルベンズアミド誘導体及びその製造法 |
| US6001862A (en) * | 1995-06-02 | 1999-12-14 | Kyorin Pharameuticals Co., Ltd. | N-benzyldioxothiazolidylbenzamide derivatives and processes for preparing the same |
| JPH101476A (ja) | 1996-02-28 | 1998-01-06 | Nissan Chem Ind Ltd | 効力が向上したチフルザミド |
| ZA971637B (en) * | 1996-02-28 | 1997-09-25 | Nissan Chemical Ind Ltd | Thifluzamide with improved efficacy. |
| GB9726566D0 (en) | 1997-12-16 | 1998-02-11 | Smithkline Beecham Plc | Novel pharmaceutical |
-
2001
- 2001-04-23 MX MXPA02010545A patent/MXPA02010545A/es not_active Application Discontinuation
- 2001-04-23 KR KR1020027014251A patent/KR20030007548A/ko not_active Application Discontinuation
- 2001-04-23 EP EP01921997A patent/EP1277745A4/en not_active Withdrawn
- 2001-04-23 SK SK1514-2002A patent/SK15142002A3/sk unknown
- 2001-04-23 AU AU48828/01A patent/AU4882801A/en not_active Abandoned
- 2001-04-23 IL IL15222401A patent/IL152224A0/xx unknown
- 2001-04-23 EE EEP200200601A patent/EE200200601A/xx unknown
- 2001-04-23 PL PL01365533A patent/PL365533A1/xx not_active Application Discontinuation
- 2001-04-23 CA CA002407349A patent/CA2407349A1/en not_active Abandoned
- 2001-04-23 BR BR0110258-3A patent/BR0110258A/pt not_active IP Right Cessation
- 2001-04-23 US US10/257,939 patent/US6770133B2/en not_active Expired - Fee Related
- 2001-04-23 HU HU0300475A patent/HUP0300475A3/hu unknown
- 2001-04-23 CZ CZ20023502A patent/CZ20023502A3/cs unknown
- 2001-04-23 WO PCT/JP2001/003450 patent/WO2001081327A1/ja not_active Application Discontinuation
- 2001-04-23 CN CN01808516A patent/CN1426402A/zh active Pending
- 2001-04-23 EA EA200201055A patent/EA004244B1/ru not_active IP Right Cessation
- 2001-04-23 YU YU80302A patent/YU80302A/sh unknown
-
2002
- 2002-10-15 ZA ZA200208293A patent/ZA200208293B/en unknown
- 2002-10-16 BG BG107200A patent/BG107200A/bg unknown
- 2002-10-21 IS IS6586A patent/IS6586A/is unknown
- 2002-10-22 NO NO20025069A patent/NO20025069D0/no not_active Application Discontinuation
- 2002-10-25 MA MA26881A patent/MA25664A1/fr unknown
-
2003
- 2003-07-22 HK HK03105306.5A patent/HK1053835A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| YU80302A (sh) | 2005-11-28 |
| EA004244B1 (ru) | 2004-02-26 |
| AU4882801A (en) | 2001-11-07 |
| MA25664A1 (fr) | 2002-12-31 |
| ZA200208293B (en) | 2003-10-06 |
| HK1053835A1 (zh) | 2003-11-07 |
| IL152224A0 (en) | 2003-05-29 |
| US20030101925A1 (en) | 2003-06-05 |
| KR20030007548A (ko) | 2003-01-23 |
| EP1277745A4 (en) | 2004-09-15 |
| CZ20023502A3 (cs) | 2003-06-18 |
| EP1277745A1 (en) | 2003-01-22 |
| BR0110258A (pt) | 2003-01-07 |
| NO20025069L (no) | 2002-10-22 |
| US6770133B2 (en) | 2004-08-03 |
| EA200201055A1 (ru) | 2003-06-26 |
| HUP0300475A2 (hu) | 2003-06-28 |
| CN1426402A (zh) | 2003-06-25 |
| SK15142002A3 (sk) | 2003-04-01 |
| NO20025069D0 (no) | 2002-10-22 |
| PL365533A1 (en) | 2005-01-10 |
| HUP0300475A3 (en) | 2004-10-28 |
| EE200200601A (et) | 2004-04-15 |
| BG107200A (bg) | 2003-11-28 |
| IS6586A (is) | 2002-10-21 |
| CA2407349A1 (en) | 2002-10-24 |
| WO2001081327A1 (fr) | 2001-11-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA02010545A (es) | Cristal estable novedoso de derivado de tiazolidinediona y proceso para producir el mismo. | |
| CA2239245A1 (en) | N-substituted dioxothiazolidylbenzamide derivatives and process for producing the same | |
| MY138452A (en) | Novel process for synthesizing and a novel crystal form of agomelatine as well as pharmaceutical preparations containing these | |
| CA2035972A1 (en) | Process for the preparation of oxetanones | |
| NO20025719D0 (no) | Nye triazolpyrimidinforbindelser | |
| WO2002083662A3 (en) | Azo compounds and process of producing the same and novel intermediate compounds used in the process of producing azo compounds | |
| CA2425560A1 (en) | Anticholinergics, processes for preparing them and their use as pharmaceutical compositions | |
| BG100951A (en) | Novel erythromycin derivatives, method for their preparation and their use as drugs | |
| MXPA04003936A (es) | Cristal en forma alfa o en forma beta de derivado de acetanilida. | |
| YU27304A (sh) | Novi dihidropteridinoni, postupak za njihovo dobijanje i njihova primena kao lekova | |
| EP1468990A4 (en) | piperazine derivative | |
| WO2001057014A3 (en) | Synthesis of 3,6-dialkyl-5,6-dihydro-4-hydroxy-pyran-2-one | |
| CA2333192A1 (en) | Synthesis of 3,6-dialkyl-5,6-dihydro-4-hydroxy-2h-pyran-2-one | |
| EP0757988A4 (en) | IMIDAZOLE DERIVATIVE AND PROCESS FOR PRODUCING THE SAME | |
| WO2000018722A3 (es) | Nuevos derivados de la 6-(4-fenilbutoxi)hexilamina y procedimiento para la obtencion de salmeterol | |
| CA2059647A1 (en) | Thiocylating reagents and intermediates, thiopeptides, and methods for preparing and using same | |
| WO2002072567A3 (en) | Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them | |
| HUT78061A (hu) | Eljárás 2-(aril-oxi)-4-klór-piridin-származékok előállítására | |
| AU2001293791A1 (en) | Process for the preparation of vitronectin receptor antagonists | |
| CA2258539A1 (en) | Ring-fused dihydropyranes, process for the preparation and use thereof | |
| IL154466A0 (en) | Process for preparing a substituted imidazopyridine compound | |
| AU2001277801A1 (en) | Process for preparing 2,3-diaminopropanols and synthesis of other compounds using 2,3-diaminopropanols | |
| CA2118052A1 (en) | N-(Substituted Amino) Pyrrole Derivatives, Preparation Process Thereof, and Herbicidal Compositions | |
| CA2289512A1 (en) | 1,2,3-thiadiazole derivatives, plant disease controller and method for using the same | |
| HUP0204444A2 (en) | Phenyl- and pyridyl-tetrahydro-pyridines, process for their preparation and pharmaceutical compositions containing them |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |